1-20 of 32
Authors: Michael Thorpy
Journal Article
0637 Composite Response with Once-Nightly Sodium Oxybate: Symptom Improvement in Participants with Narcolepsy Type 1
Sleep, Volume 47, Issue Supplement_1, May 2024, Pages A272–A273, https://doi.org/10.1093/sleep/zsae067.0637
Published: 20 April 2024
Journal Article
0646 Efficacy Outcomes Among Male and Female Participant Subgroups: A Post Hoc Analysis from REST-ON
Sleep, Volume 47, Issue Supplement_1, May 2024, Page A276, https://doi.org/10.1093/sleep/zsae067.0646
Published: 20 April 2024
Journal Article
0640 Magnitude of Improvement in Excessive Daytime Sleepiness with the Once-at-Bedtime Oxybate for Narcolepsy
Sleep, Volume 47, Issue Supplement_1, May 2024, Page A274, https://doi.org/10.1093/sleep/zsae067.0640
Published: 20 April 2024
Journal Article
1023 Solriamfetol and Maintenance of Wakefulness Outcomes in Patients with Narcolepsy and Obstructive Sleep Apnea
Sleep, Volume 47, Issue Supplement_1, May 2024, Pages A439–A440, https://doi.org/10.1093/sleep/zsae067.01023
Published: 20 April 2024
Journal Article
0628 Consistent Efficacy of Once-Nightly Sodium Oxybate Across Patient Demographic and Baseline Disease Characteristics
Sleep, Volume 47, Issue Supplement_1, May 2024, Page A268, https://doi.org/10.1093/sleep/zsae067.0628
Published: 20 April 2024
Journal Article
0645 Comparison of Demographics and Baseline Narcolepsy Symptoms Between Participants with NT1 and NT2 from REST-ON
Sleep, Volume 47, Issue Supplement_1, May 2024, Page A276, https://doi.org/10.1093/sleep/zsae067.0645
Published: 20 April 2024
Journal Article
0644 Comparison of Baseline Narcolepsy Characteristics Among Participant Age Groups: Analysis from REST-ON
Sleep, Volume 47, Issue Supplement_1, May 2024, Pages A275–A276, https://doi.org/10.1093/sleep/zsae067.0644
Published: 20 April 2024
Journal Article
0593 Functional Outcomes of Sleep Questionnaire in a phase 2 study of mazindol ER in narcolepsy
Sleep, Volume 46, Issue Supplement_1, May 2023, Page A260, https://doi.org/10.1093/sleep/zsad077.0593
Published: 29 May 2023
Journal Article
0585 A four-week randomized, double-blind, placebo-controlled, phase 2 study of mazindol ER in the treatment of narcolepsy
Sleep, Volume 46, Issue Supplement_1, May 2023, Page A257, https://doi.org/10.1093/sleep/zsad077.0585
Published: 29 May 2023
Journal Article
0578 Clinician and Patient Global Impression in a Phase 2 Study of Mazindol (NLS-1021) in Adults with Narcolepsy Type 1 and Type 2
Sleep, Volume 46, Issue Supplement_1, May 2023, Page A254, https://doi.org/10.1093/sleep/zsad077.0578
Published: 29 May 2023
Journal Article
0607 Improvement in Sleep Latency With FT218 (Once-Nightly Sodium Oxybate): Analysis From the Phase 3 REST-ON Clinical Trial
Sleep, Volume 46, Issue Supplement_1, May 2023, Page A266, https://doi.org/10.1093/sleep/zsad077.0607
Published: 29 May 2023
Journal Article
0573 Application of AASM Clinical Significance Thresholds to Once-Nightly Sodium Oxybate for Improvement in Narcolepsy Symptoms
Sleep, Volume 46, Issue Supplement_1, May 2023, Page A252, https://doi.org/10.1093/sleep/zsad077.0573
Published: 29 May 2023
Journal Article
0592 Efficacy of Lower-Sodium Oxybate by Baseline Sleep Inertia in a Phase 3 Clinical Study in Patients With Idiopathic Hypersomnia
Sleep, Volume 46, Issue Supplement_1, May 2023, Page A260, https://doi.org/10.1093/sleep/zsad077.0592
Published: 29 May 2023
Journal Article
0595 Long-term efficacy on cataplexy attacks and excessive daytime sleepiness in open-label extension study (NLS-1022) of mazindol ER
Sleep, Volume 46, Issue Supplement_1, May 2023, Page A261, https://doi.org/10.1093/sleep/zsad077.0595
Published: 29 May 2023
Journal Article
0575 Cataplexy Response With FT218 (Once-Nightly Sodium Oxybate): Post Hoc Responder Analysis From the Phase 3 Rest-ON Clinical Trial
Sleep, Volume 46, Issue Supplement_1, May 2023, Pages A252–A253, https://doi.org/10.1093/sleep/zsad077.0575
Published: 29 May 2023
Journal Article
0406 Efficacy of Once-Nightly Sodium Oxybate (ON-SXB; FT218) Across Stimulant Use Subgroups: Post-hoc Analyses From the REST-ON Trial
Sleep, Volume 45, Issue Supplement_1, June 2022, Page A182, https://doi.org/10.1093/sleep/zsac079.403
Published: 25 May 2022
Journal Article
0402 Efficacy of FT218, a Once-Nightly Sodium Oxybate Formulation, in Patients With Narcolepsy: Post-hoc Sensitivity Analyses From the REST-ON Trial
Sleep, Volume 45, Issue Supplement_1, June 2022, Page A180, https://doi.org/10.1093/sleep/zsac079.399
Published: 25 May 2022
Journal Article
0386 Long-term Safety During a Clinical Trial of Lower-Sodium Oxybate in Participants With Narcolepsy With Cataplexy
Sleep, Volume 45, Issue Supplement_1, June 2022, Page A173, https://doi.org/10.1093/sleep/zsac079.383
Published: 25 May 2022
Journal Article
0401 Efficacy of Once-Nightly Sodium Oxybate (ON-SXB; FT218) By Narcolepsy Type: Post-hoc Analyses From the REST-ON Trial
Sleep, Volume 45, Issue Supplement_1, June 2022, Pages A179–A180, https://doi.org/10.1093/sleep/zsac079.398
Published: 25 May 2022
Journal Article
0404 Patient and Provider Preferences for Oxybate Treatment for Narcolepsy: A Discrete Choice Experiment
Sleep, Volume 45, Issue Supplement_1, June 2022, Page A181, https://doi.org/10.1093/sleep/zsac079.401
Published: 25 May 2022
